While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of countries around the world, the drugmaker withdrew its FDA filing in mid-2023 ...

Nuvation Bio is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment ...

The companies have said they will create customised AI models and agents that Novo Nordisk can use for early research and ...

Type of data available on UK Pharmascan registration, with a breakdown on whether the live record is for a new indication, ...

At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.

If that sounds like the storyline to Marvel's latest superhero tale, that's because it is. The publisher's latest custom ...